ONK Therapeutics
PrivateLast Round
Series A
Jan 6, 2022
Total Funding Raised
$33.45M
Company Overview
ONK Therapeutics is a biotechnology company that develops next-generation, off-the-shelf, optimally engineered natural killer (NK) cell therapies for the treatment of hematological malignancies and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ONK Therapeutics Comparables
Compare ONK Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoImmune Therapeutics | 89% | |
| NK:IO | 84% | |
| Glycostem Therapeutics | 83% | |
ONK Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 6, 2022 | ||||
| Grant | Jun 8, 2021 | ||||
| VC Round | Oct 19, 2020 | ||||
| Seed | May 1, 2020 | ||||
| Grant | Dec 10, 2018 |
ONK Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cormorant Asset Management | Series A |
| Acorn Bioventures | Series A, VC Round |
| Enterprise Ireland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 39% MoM.
- Nov 9, 2025
Monthly visitors increased 46% MoM.
ONK Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ONK Therapeutics's valuation, stock price, and market status.